Avita Medical reported AUD58.13M in Assets for its fiscal semester ending in June of 2025.





Assets Change Date
Accuray USD 456.82M 13.42M Sep/2025
Celltrion KRW 21.08T 530.63B Sep/2025
Clinuvel Pharmaceuticals AUD 231.12M 19.44M Jun/2024
Cochlear AUD 2.82B 38.9M Jun/2025
CSL USD 39.4B 957M Jun/2025
Cspc Pharmaceutical CNY 46B 1.61B Jun/2025
Deva Holding AS TRY 12.93B 1.83B Sep/2023
Dianthus Therapeutics USD 577.44M 251.37M Sep/2025
Divis Laboratories Ltd INR 181.51B 12.19B Sep/2025
Kangmei Pharma CNY 13.68B 38.19M Sep/2025
Knight Therapeutics CAD 962.29M 16.93M Sep/2024
Laboratorios Farma EUR 799.88M 99.95M Dec/2023
Malin Corporation EUR 198.5M 70.1M Dec/2024
Mayne Pharma AUD 1.14B 9.47M Jun/2024
Medical Developments International AUD 66.4M 1.06M Jun/2025
Nanosonics AUD 272.48M 17.45M Jun/2025
Neuren Pharmaceuticals AUD 331.25M 78.46M Jun/2025
Organigram Holdings CAD 562.21M 2.4M Sep/2025
Ovoca Bio EUR 11.41M 3.36M Jun/2022
Pacific Edge NZD 34.66M 2.37M Dec/2025
Paradigm Biopharmaceuticals AUD 24.57M 10.79M Jun/2025
Pharma Mar EUR 341.66M 6.59M Sep/2025
Polynovo AUD 108.72M 11.51M Jun/2024
PYC Therapeutics AUD 183.28M 115.05M Jun/2025
Qiagen NV USD 6.3B 257.54M Dec/2025
Ramsay Health Care AUD 22.48B 1.82B Jun/2025
ResMed USD 8.5B 195.02M Dec/2025
Sartorius EUR 9.61B 413.4M Sep/2025
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
Telix Pharmaceuticals AUD 1.16B 25.97M Dec/2025
Tilray USD 2.07B 1.33B Mar/2025
Zz Pientze Pharmaceu CNY 17.48B 1.23B Sep/2025